JAMECA PETTIS: Open Payments
NPI 1396597506 · LA PLACE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 9 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $71 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $186 |
| Indivior Inc. | 1 | $125 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: ARISTADA, SUBLOCADE, VIVITROL, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
